# Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade

> **NCT03757117** · PHASE4 · COMPLETED · sponsor: **Asociación Civil Impacta Salud y Educación, Peru** · enrollment: 220 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Feminizing hormone therapy
- **BEHAVIORAL:** Peer navigation

## Key facts

- **NCT ID:** NCT03757117
- **Lead sponsor:** Asociación Civil Impacta Salud y Educación, Peru
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2018-11-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03757117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03757117, "Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03757117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*